IDEXX-BioAnalytics-Research-Podcast-Individual-Page-RF-Logo

    image track image track
    Episode 24 Tommy Jackson
    postcad icon Research Forward
    calendar icon November 19, 2025
    time icon 00:54:45

    Breaking Barriers in Clinical Research: How Prelude Is Redefining Data Management

    0:00
    0:00
    volumn icon volumn icon

    IN THIS EPISODE

    In this episode of Research Forward, we sit down with Tommy Jackson, CEO of Prelude, to explore how technology is transforming clinical research. Tommy shares his journey from finance and Silicon Valley startups to leading one of the most trusted eClinical platforms in animal health—and now expanding into human health trials. We discuss:

    • How Prelude’s Electronic Data Capture (EDC) system accelerates trial timelines by up to 50% and reduces database build times by 75%.
    • Lessons human health research can learn from decades of optimization in veterinary trials.
    • Why user-friendly design and integrated modules like ePRO and eConsent are critical for trial success.
    • The role of robust customer success teams in overcoming resistance to digital adoption.
    • How modern EDC systems support compliance, improve data quality, and even help advance the “Three Rs” in animal research.
    If you’ve ever wondered how clinical data management can evolve to be faster, more accurate, and more humane, this conversation is for you.

     

     

     

    ABOUT TOMMY JACKSON

    Tommy Jackson is the Chief Executive Officer of Prelude, a leading eClinical technology company serving animal and human health research. Since joining Prelude in 2018 as COO and stepping into the CEO role in 2021, Tommy has driven the company’s expansion from its roots in veterinary trials to broader applications in biotech, pharma, and academia.

    A graduate of Brigham Young University and Northwestern’s Kellogg School of Management, Tommy began his career in investment banking before moving into the tech startup world. His entrepreneurial path eventually led him to Prelude, where he combines a passion for building businesses with a mission to improve the clinical research experience. Under his leadership, Prelude continues to set the standard for user-friendly, integrated EDC solutions that accelerate lifesaving innovation.